Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

New data registry will track how AI-powered plaque assessments impact cardiologist decisions

HeartFlow hopes to gather real-world data from up to 10,000 patients with suspected CAD.

March 27, 2024
Avicenna.AI, a French artificial intelligence (AI) startup co-founded by a radiologist, has received U.S. Food and Drug Administration (FDA) clearance for two new offerings designed to automatically identify cardiovascular findings in CT scans, CINA-iPE and CINA-ASPECTS.

Radiology AI company gains FDA clearance for new CT offerings focused on PE, stroke

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

March 26, 2024
Video interview with Tim Bateman, MD, co-director, cardiovascular radiologic imaging program, Saint Luke's Mid America Heart Institute and an American Society of Nuclear Cardiology (ASNC) past-president, explaining the role of SPECT into the future as PET becomes more popular. A new look at PET vs SPECT.

SPECT still has an important role to play in nuclear cardiology

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

March 26, 2024
Virtual reality (VR) can help cardiologists plan for transcatheter aortic valve replacement (TAVR) procedures and predict the presence and severity of post-TAVR paravalvular leak (PVL), according to new research published in the Journal of Invasive Cardiology.[1]

VR before TAVR predicts paravalvular leak in high-risk patients

Performing virtual reality simulations before TAVR may help cardiologists anticipate when PVL could be an issue in patients with severe BAV AS.

March 25, 2024
Biosense Webster gained CE mark approval for its Varipulse pulsed field ablation (PFA) system in Europe

Biosense Webster takes key step toward FDA approval for Varipulse PFA system

The company already received CE mark approval for its new PFA offering and hopes it will soon be approved for sale in the United States.

March 25, 2024
Powering down angiography and fluoroscopy systems at night and on weekends could significantly reduce cardiology department energy bills, new study finds.Photo by Jose Arellano

Going green in the cath lab makes economic sense

New research explored the potential savings of turning off angiography systems at night and on weekends.

March 22, 2024
IVUS with coregistration with angiography displayed by Philips at TCT 2023. Photo by Dave Fornell

Expert calls for education, research to spur adoption of intravascular ultrasound

Eric Secemsky, MD, from Beth Israel Deaconess Medical Center and Harvard Medical School, says a lack of hands-on training and reimbursement challenges are hindering the adoption of IVUS.

March 21, 2024
The U.S. Food and Drug Administration (FDA) has announced that Abiomed is recalling its instructions for certain Impella left-sided blood pumps due to significant safety concerns. New and revised instructions for use (IFU) have been sent to all affected customers.

FDA announces new recall impacting more than 66,000 Impella heart pumps after 49 deaths

More than 100 patients have been seriously injured as a result of a significant safety concern. The Impella devices can still be used, according to the recall, if customers refer to Abiomed's new and revised instructions for use.

March 21, 2024